+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomaterials Market Size, Share & Trends Analysis Report by Product (Natural, Metallic, Polymer), Application (Cardiovascular, Orthopedics, Plastic Surgery), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 170 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 4751754
Description Jump to:
The global biomaterials market size is expected to reach USD 488.70 billion by 2030, registering a CAGR of 15.6% over the forecast period. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocytes’ extracellular matrix, thus replacing the traditional organ transplantation procedures.

Biomaterials Market Report Highlights

  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • The infection from coronavirus, that is, SARS-COV-2 can be detected using existing biomedical devices which are based on either Polymerase Chain Reaction (PCR) or Non-PCR methods
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • Biosensor, is an analytical device that is used to detect analytes such as biomolecules or biological elements of species produced by micro-organisms, that is tissues, enzymes, and organelles
  • North America is expected to dominate the market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in March 2022, Medtronic announced a collaboration with Vizient to add Touch Surgery Enterprise to Vizient's portfolio, which is an AI-powered video management and analytical platform that provides surgical teams with simple access to procedural recordings and insights

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Primary Sources
1.11. List of Abbreviations
Chapter 2. Biomaterials Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshots
2.3. Competitive Landscape Snapshot
Chapter 3. Biomaterials Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Rising Demand as a Consequence of Accidental Injuries & Chronic Conditions
3.3.1.2. Advances in Biomaterials Technologies
3.3.1.3. Expansion in the Usage Scope of Biomaterials
3.3.2. Market Restraint Analysis
3.3.2.1. High Expense Associated with the Development of Biomaterials
3.3.2.2. Problems Related to Biocompatibility of Biomaterials
3.4. Biomaterials Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PESTLE Analysis
Chapter 4. Biomaterials Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Biomaterials Market by Product Outlook
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.3.1. Metallic
4.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.3.2. Natural
4.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.3.3. Ceramics
4.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.3.4. Polymers
4.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Biomaterials Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Biomaterials Market by Application Outlook
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.3.1. Cardiovascular
5.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.2. Sensors
5.3.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.3. Stents
5.3.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.4. Guidewires
5.3.1.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.5. Implantable Cardiac Defibrillators
5.3.1.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.6. Pacemakers
5.3.1.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.7. Vascular Grafts
5.3.1.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.1.8. Others
5.3.1.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2. Ophthalmology
5.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2.2. Synthetic Corneas
5.3.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2.3. Intraocular Lens
5.3.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2.4. Contact Lens
5.3.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2.5. Ocular Tissue Replacement
5.3.2.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2.6. Others
5.3.2.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.3. Dental
5.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.3.2. Tissue Regeneration Materials
5.3.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.3.3. Dental Implants
5.3.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.3.4. Bone Grafts & Substitutes
5.3.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.3.5. Dental Membranes
5.3.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.3.6. Others
5.3.3.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4. Orthopedic
5.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4.2. Joint Replacement Biomaterials
5.3.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4.3. Orthobiologics
5.3.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4.4. Bioresorbable Tissue Fixation Products
5.3.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4.5. Visco Supplementation
5.3.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4.6. Spine Biomaterial
5.3.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.4.7. Others
5.3.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5. Wound Healing
5.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5.2. Fracture Healing Device
5.3.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5.3. Adhesion Barrier
5.3.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5.4. Skin Substitutes
5.3.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5.5. Internal Tissue Sealant
5.3.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5.6. Surgical Hemostats
5.3.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.5.7. Others
5.3.5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.6. Tissue Engineering
5.3.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7. Plastic Surgery
5.3.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.2. Facial Wrinkle Treatment
5.3.7.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.3. Soft Tissue Fillers
5.3.7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.4. Craniofacial Surgery
5.3.7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.5. Bioengineered Skins
5.3.7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.6. Peripheral Nerve Repair
5.3.7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.7. Acellular Dermal Matrices
5.3.7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.7.8. Others
5.3.7.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.8. Neurology
5.3.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.8.2. Neural Stem Cell Encapsulation
5.3.8.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.8.3. Shunting Systems
5.3.8.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.8.4. Hydrogel Scaffold for CNS Repair
5.3.8.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.8.5. Cortical Neural Prosthetics
5.3.8.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.8.6. Others
5.3.8.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.9. Others
5.3.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Biomaterials Market: Regional Business Analysis
6.1. Regional Market Dashboard
6.2. Global Regional Market Snapshot
6.3. Marker Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.4. Spain
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.5. France
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.6. Italy
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.7. Australia
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.3. Mexico
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Mexico Biomaterials Market, 2018-2030 (USD Million)
6.7.4. Argentina
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8. MEA
6.8.1. MEA Biomaterials Market, 2018-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Biomaterials Market: Competitive Landscape
7.1. Participant Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2023
7.4. Participant’s Overview
7.4.1. Medtronic
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Evonik Industries AG
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Carpenter Technology Corporation
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Berkeley Advanced Biomaterials
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Invibio Ltd
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Zimmer Biomet Holdings, Inc
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. BASF SE
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Covalon Technologies Ltd
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Stryker
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Johnson & Johnson
7.4.10.1. Overview
7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Dentsply Sirona
7.4.11.1. Overview
7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. CoorsTek Inc
7.4.12.1. Overview
7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.12.3. Product Benchmarking
7.4.12.4. Strategic Initiatives
7.4.13. Corbion
7.4.13.1. Overview
7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.13.3. Product Benchmarking
7.4.13.4. Strategic Initiatives
7.4.14. Regenity Biosciences
7.4.14.1. Overview
7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.14.3. Product Benchmarking
7.4.14.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America Biomaterials Market, Region, 2018-2030 (USD Million)
Table 3 North America Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 4 North America Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 5 U.S. Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 6 U.S. Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 7 Canada Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 8 Canada Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 9 Europe Biomaterials Market, Region, 2018-2030 (USD Million)
Table 10 Europe Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 11 Europe Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 12 UK Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 13 UK Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 14 Germany Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 15 Germany Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 16 France Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 17 France Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 18 Italy Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 19 Italy Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 20 Spain Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 21 Spain Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 22 Sweden Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 23 Sweden Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 24 Norway Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 25 Norway Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 26 Denmark Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 27 Denmark Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 28 Asia-Pacific Biomaterials Market, Region, 2018-2030 (USD Million)
Table 29 Asia-Pacific Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 30 Asia-Pacific Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 31 Japan Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 32 Japan Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 33 China Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 34 China Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 35 India Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 36 India Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 37 Australia Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 38 Australia Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 39 South Korea Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 40 South Korea Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 41 Thailand Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 42 Thailand Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 43 Latin America Biomaterials Market, Region, 2018-2030 (USD Million)
Table 44 Latin America Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 45 Latin America Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 46 Brazil Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 47 Brazil Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 48 Mexico Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 49 Mexico Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 50 Argentina Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 51 Argentina Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 52 MEA Biomaterials Market, Region, 2018-2030 (USD Million)
Table 53 MEA Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 54 MEA Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 55 South Africa Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 56 South Africa Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 57 Saudi Arabia Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 58 Saudi Arabia Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 59 UAE Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 60 UAE Biomaterials Market, by Application, 2018-2030 (USD Million)
Table 61 Kuwait Biomaterials Market, by Product, 2018-2030 (USD Million)
Table 62 Kuwait Biomaterials Market, by Application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews in North America
Figure 5 Primary Interviews in Europe
Figure 6 Primary Interviews in APAC
Figure 7 Primary Interviews in Latin America
Figure 8 Primary Interviews in MEA
Figure 9 Market Research Approaches
Figure 10 Value-Chain-based Sizing & Forecasting
Figure 11 QFD Modeling for Market Share Assessment
Figure 12 Market Formulation & Validation
Figure 13 Biomaterials Market: Market Outlook
Figure 14 Biomaterials Competitive Insights
Figure 15 Parent Market Outlook
Figure 16 Related/Ancillary Market Outlook
Figure 17 Penetration and Growth Prospect Mapping
Figure 18 Industry Value Chain Analysis
Figure 19 Biomaterials Market Driver Impact
Figure 20 Biomaterials Market Restraint Impact
Figure 21 Biomaterials Market Strategic Initiatives Analysis
Figure 22 Biomaterials Market: Product Movement Analysis
Figure 23 Biomaterials Market: Product Outlook and Key Takeaways
Figure 24 Logistics & Distribution Market Estimates and Forecast, 2018-2030
Figure 25 Metallic Market Estimates and Forecast, 2018-2030
Figure 26 Natural Market Estimates and Forecast, 2018-2030
Figure 27 Ceramics Market Estimates and Forecast, 2018-2030
Figure 28 Polymers Market Estimates and Forecast, 2018-2030
Figure 29 Biomaterials Market: Application Movement Analysis
Figure 30 Biomaterials Market: Application Outlook and Key Takeaways
Figure 31 Cardiovascular Market Estimates and Forecasts, 2018-2030
Figure 32 Ophthalmology Market Estimates and Forecasts, 2018-2030
Figure 33 Dental Market Estimates and Forecasts, 2018-2030
Figure 34 Orthopedic Market Estimates and Forecasts, 2018-2030
Figure 35 Wound Healing Market Estimates and Forecasts, 2018-2030
Figure 36 Tissue Engineering Market Estimates and Forecasts, 2018-2030
Figure 37 Plastic Surgery Market Estimates and Forecasts, 2018-2030
Figure 38 Neurology Market Estimates and Forecasts, 2018-2030
Figure 39 Others Market Estimates and Forecasts, 2018-2030
Figure 40 Global Biomaterials Market: Regional Movement Analysis
Figure 41 Global Biomaterials Market: Regional Outlook and Key Takeaways
Figure 42 Global Biomaterials Market Share and Leading Players
Figure 43 North America Market Share and Leading Players
Figure 44 Europe Market Share and Leading Players
Figure 45 Asia-Pacific Market Share and Leading Players
Figure 46 Latin America Market Share and Leading Players
Figure 47 Middle East & Africa Market Share and Leading Players
Figure 48 North America: SWOT
Figure 49 Europe SWOT
Figure 50 Asia-Pacific SWOT
Figure 51 Latin America SWOT
Figure 52 MEA SWOT
Figure 53 North America, by Country
Figure 54 North America
Figure 55 North America Market Estimates and Forecasts, 2018-2030
Figure 56 U.S.
Figure 57 U.S. Market Estimates and Forecasts, 2018-2030
Figure 58 Canada
Figure 59 Canada Market Estimates and Forecasts, 2018-2030
Figure 60 Europe
Figure 61 Europe Market Estimates and Forecasts, 2018-2030
Figure 62 UK
Figure 63 UK Market Estimates and Forecasts, 2018-2030
Figure 64 Germany
Figure 65 Germany Market Estimates and Forecasts, 2018-2030
Figure 66 France
Figure 67 France Market Estimates and Forecasts, 2018-2030
Figure 68 Italy
Figure 69 Italy Market Estimates and Forecasts, 2018-2030
Figure 70 Spain
Figure 71 Spain Market Estimates and Forecasts, 2018-2030
Figure 72 Denmark
Figure 73 Denmark Market Estimates and Forecasts, 2018-2030
Figure 74 Sweden
Figure 75 Sweden Market Estimates and Forecasts, 2018-2030
Figure 76 Norway
Figure 77 Norway Market Estimates and Forecasts, 2018-2030
Figure 78 Asia-Pacific
Figure 79 Asia-Pacific Market Estimates and Forecasts, 2018-2030
Figure 80 China
Figure 81 China Market Estimates and Forecasts, 2018-2030
Figure 82 Japan
Figure 83 Japan Market Estimates and Forecasts, 2018-2030
Figure 84 India
Figure 85 India Market Estimates and Forecasts, 2018-2030
Figure 86 Thailand
Figure 87 Thailand Market Estimates and Forecasts, 2018-2030
Figure 88 South Korea
Figure 89 South Korea Market Estimates and Forecasts, 2018-2030
Figure 90 Australia
Figure 91 Australia Market Estimates and Forecasts, 2018-2030
Figure 92 Latin America
Figure 93 Latin America Market Estimates and Forecasts, 2018-2030
Figure 94 Brazil
Figure 95 Brazil Market Estimates and Forecasts, 2018-2030
Figure 96 Mexico
Figure 97 Mexico Market Estimates and Forecasts, 2018-2030
Figure 98 Argentina
Figure 99 Argentina Market Estimates and Forecasts, 2018-2030
Figure 100 Middle East and Africa
Figure 101 Middle East and Africa Market Estimates and Forecasts, 2018-2030
Figure 102 South Africa
Figure 103 South Africa Market Estimates and Forecasts, 2018-2030
Figure 104 Saudi Arabia
Figure 105 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 106 UAE
Figure 107 UAE Market Estimates and Forecasts, 2018-2030
Figure 108 Kuwait
Figure 109 Kuwait Market Estimates and Forecasts, 2018-2030
Figure 110 Market Share of Key Market Players- Biomaterials Market

Companies Mentioned

  • Medtronic
  • Evonik Industries AG
  • Carpenter Technology Corporation
  • Berkeley Advanced Biomaterials
  • Invibio Ltd
  • Zimmer Biomet Holdings, Inc
  • BASF SE
  • Covalon Technologies Ltd
  • Stryker
  • Johnson & Johnson
  • Dentsply Sirona
  • CoorsTek Inc
  • Corbion
  • Regenity Biosciences

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages170
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 178 Billion
Forecasted Market Value ( USD ) by 2030 $ 488.7 Billion
Compound Annual Growth Rate15.6%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Biomaterials Market by Type (Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2029 - Product Image

Biomaterials Market by Type (Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2029

  • Report
  • 664 Pages
  • Global
From
Biomaterials - Global Strategic Business Report - Product Image

Biomaterials - Global Strategic Business Report

  • Report
  • 134 Pages
  • Global
From
Orthopedic Biomaterials Market Size, Share & Trends Analysis Report By Material (Metal, Polymers, Ceramics & Bioactive Glass Biomaterials), By Application (Orthobiologics, Orthopedic Implants), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Orthopedic Biomaterials Market Size, Share & Trends Analysis Report By Material (Metal, Polymers, Ceramics & Bioactive Glass Biomaterials), By Application (Orthobiologics, Orthopedic Implants), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Biomaterial Wound Dressing Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Biomaterial Wound Dressing Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Biomaterials Market by Type, Classification, Application - Global Forecast 2025-2030 - Product Image

Biomaterials Market by Type, Classification, Application - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.